Neothetics to Release First Quarter 2015 Financial Results, Host Annual Stockholder Meeting
May 07, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, May 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it...
Neothetics Initiates Pivotal Phase 3 Clinical Trials for LIPO-202, the First Non-Invasive Injectable Drug Candidate for Reduction of Subcutaneous Abdominal Fat
April 13, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, April 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics to Present at Needham & Company's 14th Annual Healthcare Conference
April 08, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results
March 26, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
Neothetics Initiates Study to Evaluate Safety of Retreatment With LIPO-202 for Body Contouring
March 23, 2015 09:30 ET
|
Neothetics, Inc.
SAN DIEGO, March 23, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced it has...
Neothetics to Present at the 27th Annual Roth Conference
March 04, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, March 4, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Neothetics to Present at Cowen and Company 35th Annual Health Care Conference
February 25, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Leading Aesthetic Physicians Join Neothetics' Newly Formed Corporate Advisory Board
February 12, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Announces Closing of Upsized Initial Public Offering
December 01, 2014 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Prices Initial Public Offering
November 19, 2014 19:35 ET
|
Neothetics, Inc.
SAN DIEGO, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...